BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 17874717)

  • 41. Effects of ultrasound-guided botulinum toxin type-A injections with a specific approach in spastic cerebral palsy.
    Büyükavcı R; Büyükavcı MA
    Acta Neurol Belg; 2018 Sep; 118(3):429-433. PubMed ID: 29694645
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term effect of botulinum toxin (A) in the management of calf spasticity in children with diplegic cerebral palsy.
    Hawamdeh ZM; Ibrahim AI; Al-Qudah AA
    Eura Medicophys; 2007 Sep; 43(3):311-8. PubMed ID: 17268388
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Usefulness of the tendon reflex for assessing spasticity after botulinum toxin-a injection in children with cerebral palsy.
    Jang DH; Sung IY; Kang YJ
    J Child Neurol; 2013 Jan; 28(1):21-6. PubMed ID: 22832767
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Botulinum toxin type A management of spasticity in the context of orthopaedic surgery for children with spastic cerebral palsy.
    Graham HK
    Eur J Neurol; 2001 Nov; 8 Suppl 5():30-9. PubMed ID: 11851732
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE.
    Chaléat-Valayer E; Parratte B; Colin C; Denis A; Oudin S; Bérard C; Bernard JC; Bourg V; Deleplanque B; Dulieu I; Evrard P; Filipetti P; Flurin V; Gallien P; Héron-Long B; Hodgkinson I; Husson I; Jaisson-Hot I; Maupas E; Meurin F; Monnier G; Pérennou D; Pialoux B; Quentin V; Moreau MS; Schneider M; Yelnik A; Marque P
    Eur J Paediatr Neurol; 2011 Sep; 15(5):439-48. PubMed ID: 21745754
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intrinsic properties and functional changes in spastic muscle after application of BTX-A in children with cerebral palsy: systematic review.
    García Salazar LF; dos Santos GL; Pavão SL; Rocha NA; de Russo TL
    Dev Neurorehabil; 2015 Feb; 18(1):1-14. PubMed ID: 25180438
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The First Russian Consensus on the Multilevel Abobotulinumtoxin A Injections in Spastic Forms of Cerebral Palsy].
    Kurenkov AL; Klochkova OA; Zmanovskaya VA; Falkovskiy IV; Kenis VM; Vladykina LN; Krasavina DA; Nosko AS; Rychkova LV; Karimova KM; Bursagova BI; Namazova-Baranova LS; Mamedyarov AM; Kuzenkova LM; Dontzov OG; Ryzhenkov MA; Butorina MN; Pavlova OL; Harlamova NN; Dankov DM; Levitina EV; Popkov DA; Ryabykh SO; Medvedeva SN; Gubina EB; Agranovich OV; Kiseleva TI; Vasileva ON; Zykov VP; Mihnovich VI; Belogorova ТА
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11):121-130. PubMed ID: 28091513
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Botulinum Toxin A Injection in Treatment of Upper Limb Spasticity in Children with Cerebral Palsy: A Systematic Review of Randomized Controlled Trials.
    Farag SM; Mohammed MO; El-Sobky TA; ElKadery NA; ElZohiery AK
    JBJS Rev; 2020 Mar; 8(3):e0119. PubMed ID: 32224633
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Botulinum toxin for postoperative care after limb surgery in cerebral palsy children].
    Dohin B; Garin C; Vanhems P; Kohler R
    Rev Chir Orthop Reparatrice Appar Mot; 2007 Nov; 93(7):674-81. PubMed ID: 18065878
    [TBL] [Abstract][Full Text] [Related]  

  • 50. No change in calf muscle passive stiffness after botulinum toxin injection in children with cerebral palsy.
    Alhusaini AA; Crosbie J; Shepherd RB; Dean CM; Scheinberg A
    Dev Med Child Neurol; 2011 Jun; 53(6):553-8. PubMed ID: 21574991
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Managing spasticity in pediatric cerebral palsy using a very low dose of botulinum toxin type A: preliminary report.
    Suputtitada A
    Am J Phys Med Rehabil; 2000; 79(4):320-6. PubMed ID: 10892617
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of Efficacy and Side Effects of Oral Baclofen Versus Tizanidine Therapy with Adjuvant Botulinum Toxin Type A in Children With Cerebral Palsy and Spastic Equinus Foot Deformity.
    Dai AI; Aksoy SN; Demiryürek AT
    J Child Neurol; 2016 Feb; 31(2):184-9. PubMed ID: 25999301
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of physiotherapeutic intervention on the gait after the application of botulinum toxin in children with cerebral palsy: systematic review.
    Fonseca PR; Calhes Franco de Moura R; Galli M; Santos Oliveira C
    Eur J Phys Rehabil Med; 2018 Oct; 54(5):757-765. PubMed ID: 29185676
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Longitudinal assessment of gait quality in children with bilateral cerebral palsy following repeated lower limb intramuscular Botulinum toxin-A injections.
    Read FA; Boyd RN; Barber LA
    Res Dev Disabil; 2017 Sep; 68():35-41. PubMed ID: 28735160
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors predicting the efficacy of botulinum toxin-A treatment of the lower limb in children with cerebral palsy.
    Fazzi E; Maraucci I; Torrielli S; Motta F; Lanzi G
    J Child Neurol; 2005 Aug; 20(8):661-6. PubMed ID: 16225811
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Efficacy and safety of botulinum toxin type A (IncobotulinumtoxinA) in the treatment of patients with cerebral palsy].
    Kurenkov AL; Klochkova OA; Bursagova BI; Karimova HM; Kuzenkova LM; Mamedyarov AM; Namazova-Baranova LS; Agranovich OV; Agranovich AO; Soboleva OA; Khapaeva MM; Batysheva TT; Sarzhina MN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):37-44. PubMed ID: 29265085
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Botulinum toxin type A (Incobotulinum toxin A) in spastic forms of cerebral palsy: a retrospective analysis of clinical experience].
    Kurenkov AL; Kuzenkova LM; Bursagova BI; Klochkova OA; Chernikov VV; Kuznetsova MA; Ashrafova US; Kuprianova OS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(7):68-77. PubMed ID: 32790979
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Botulinum Toxin Type A Injection for Spastic Equinovarus Foot in Children with Spastic Cerebral Palsy: Effects on Gait and Foot Pressure Distribution.
    Choi JY; Jung S; Rha DW; Park ES
    Yonsei Med J; 2016 Mar; 57(2):496-504. PubMed ID: 26847306
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of botulinum toxin type A injection into the gastrocnemius muscle on sit-to-stand transfer in children with spastic diplegic cerebral palsy.
    Park ES; Park CI; Chang HC; Park CW; Lee DS
    Clin Rehabil; 2006 Aug; 20(8):668-74. PubMed ID: 16944824
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Development of motor functions and manual abilities in pediatric patients with spastic cerebral palsy after botulinum toxin treatment and complex rehabilitation].
    Klochkova OA; Kurenkov AL; Namazova-Baranova LS; Mamed'iarov AM; Zherdev KV
    Vestn Ross Akad Med Nauk; 2013; (11):38-48. PubMed ID: 24640730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.